Pharmacological Evaluation of the Natural Constituent of Cannabis Sativa, Cannabichromene and its Modulation by Δ9-Tetrahydrocannabinol* 19 Aug Dr D Effects of delta9-tetrahydrocannabinol and cannabinol in man. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?